Qkine writes: We are delighted to announce the provision of a new range of high quality food grade growth factors as part of our commitment to driving innovation in the functional recombinant protein supply chain for emerging sectors.

AI-informed mental health innovators Psyomics announce two big wins

Afin Bank, a digital lender created to help people from Africa living and working in the UK, has picked Thought Machine as its core banking provider.

Researchers from Queen Mary University of London and Paragraf Limited have reported a 'significant step forward in the development of graphene-based memristors' for potential use in future computing systems and artificial intelligence (AI).

In this article, Dr Raminderpal Singh speaks to Janette Thomas of Five Alarm Bio for a biotech CEO’s perspective on the complexity of data faced by both large and small biotechs. Janette is on a mission to develop drugs targeting the chronic diseases associated with ageing. She shares her insights on the challenges and opportunities in the biotech sector, particularly for early-stage companies, and how the industry can better harness data and technology to drive innovation.

Three companies with Cambridge connections – two based in the city – have been named by Bloomberg among its 25 Startups to Watch. Cambridge based Sano Genetics and Secondmind are in the pantheon along with Wayve whose founder and CEO completed his PhD at The University of Cambridge.

DeepHealth has announced its acquisition of UK-based Kheiron Medical Technologies, marking a significant consolidation in the AI-powered breast cancer screening space. The acquisition brings together DeepHealth’s Smart Mammo platform with Kheiron’s Mia (Mammography Intelligent Assessment) suite of solutions.

Acquisition expands Axol’s iPSC-derived cell models and service offering to include ophthalmology and dermatology

A brilliant idea for helping cancer patients is just that – an idea – until it is put into practice.

Where You At (WYA), is a female-founded mesh technology platform designed to help make congested events safer. It uses indoor mapping and mesh hardware to help users stay connected in busy events, enabling people to communicate even when there is no phone signal. It has raised significant funding which has helped it make a huge impact in a short space of time.

Antiverse, a techbio company designing antibodies for challenging targets, has announced the successful closure of €4.2 million seed funding round. This latest investment brings the company’s total equity financing to €8.6 million, marking a significant step in its mission to revolutionize antibody design using generative AI technology.

The programme runs until 14 February 2025 and will provide 470,000 civil servants with the tools, skills, and motivation to generate and experiment with new ideas.